11 completed, 5 unknown, 2 recruiting. 5 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Adverse Drug Reactions: new trials by email Literature Review of Adverse Drug Reactions trials Research Report on Adverse Drug Reactions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison Retrospective medical record data analysis only, no clinical intervention - Adverse Drug Reactions, Clinical Decision Support | Recruiting | Peking University Third Hospital | 20000 | 2026-06-19 | 2026-09-09 | |
| Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions stimulation with EB virus - Adverse Drug Reactions | Unknown | First Affiliated Hospital of Kunming Medical University | 27 | 2020-12-01 | 2024-06-13 | |
| Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study. Qizhi Tongluo Capsules - Safety Surveillance, Adverse Drug Events | Unknown | Zhong Wang | 30000 | 2020-08-17 | 2022-11-15 | |
| Ofloxacin Concentration-toxicity Relationship in the Elderly ofloxacin, questionnaire, Ofloxacin Serum concentration - Ofloxacin, Bone and Joint Infection | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 110 | 2020-06-02 | 2025-06-10 |
| The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children Survey - Adverse Drug Reactions | Not applicable | Completed | Saglik Bilimleri Universitesi | 354 | 2020-01-01 | 2020-09-21 |
| Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy Voriconazole - Adverse Drug Reactions | Unknown | Dokuz Eylul University | 62 | 2019-11-01 | 2021-02-08 | |
| The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole Voriconazole - Adverse Drug Reactions | Unknown | Dokuz Eylul University | 34 | 2019-11-01 | 2020-09-16 | |
| Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study Xueshuantong-Injection - Adverse Drug Event, Adverse Drug Reactions | Unknown | Zhong Wang | 30000 | 2019-02-18 | 2021-07-07 | |
| Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events CAR T-cell and Cellular Therapies - Adverse Drug Reactions, Cancer | Completed | Groupe Hospitalier Pitie-Salpetriere | 100000 | 2019-01-01 | 2023-04-13 | |
| Pharmacogenetic Testing Among Home Health Patients Pharmacogenetic testing - Adverse Drug Events, Adverse Drug Reactions | Not applicable | Completed | Genelex Corporation | 110 | 2015-03-01 | 2019-09-20 |
| YouScript IMPACT Registry Adverse Drug Events, Adverse Drug Reactions | Completed | Genelex Corporation | 800 | 2014-10-01 | 2017-03-01 | |
| Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study Compound Kuh-seng Injection - Safety Surveillance, Adverse Drug Events | Completed | Zhong Wang | 30283 | 2014-09-01 | 2018-10-10 | |
| Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons SENATOR software generated pharmacotherapy advice report. - Adverse Drug Reactions | Not applicable | Completed | University College Cork | 1537 | 2014-07-09 | 2019-01-22 |
| Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years Qingkailing Injection - Adverse Drug Events, Adverse Drug Reactions | Completed | China Academy of Chinese Medical Sciences | 30840 | 2013-01-01 | 2018-02-19 | |
| The Effect of Medication Review in High-risk Emergency Department Patients Pharmacist-led medication review - Adverse Drug Events, Adverse Drug Reactions | Not applicable | Completed | University of British Columbia | 10805 | 2012-12-01 | 2014-04-25 |
| Adverse Drug Event Prevention Using Structured Pharmacist Review Structured expert pharmacist review, No Intervention - Adverse Drug Reactions | Phase 4 | Completed | University College Cork | 720 | 2011-06-01 | 2012-06-06 |
| A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women Adverse Drug Reactions | Completed | Adimmune Corporation | 398 | 2010-06-01 | 2011-05-17 | |
| Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward Collection of adverse drug events - Adverse Drug Reactions | Completed | University of Zurich | 129 | 2007-08-01 | 2018-05-11 |
Drug-Related Side Effects and Adverse Reactions (18) · Drug Metabolism, Poor, CYP2C19-Related (2) · Drug Metabolism, Poor, CYP2D6-Related (2) · Hematologic Neoplasms (2) · Anaphylaxis (1) · Neoplasms (1) · Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, Type 2 (1)
Chemically-Induced Disorders (18) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1)
Surveys and Questionnaires (2) · Voriconazole (2) · Immunotherapy, Adoptive (1) · Ofloxacin (1) · Pharmacogenomic Testing (1) · Qingkailing (1)
Zhong Wang (3) · Dokuz Eylul University (2) · Genelex Corporation (2) · University College Cork (2) · Adimmune Corporation (1) · Centre Hospitalier Universitaire, Amiens (1) · China Academy of Chinese Medical Sciences (1) · First Affiliated Hospital of Kunming Medical University (1) · Groupe Hospitalier Pitie-Salpetriere (1) · Peking University Third Hospital (1) · Saglik Bilimleri Universitesi (1) · University of British Columbia (1) · University of Zurich (1)
China (6) · Turkey (Türkiye) (3) · France (2) · Ireland (2) · United States (2) · Canada (1) · Switzerland (1)
Mukaddes Gumustekin, Professor, MD, PhD (2) · Zhong Wang, M.D. (2) · Adalsteinn Gudmundsson, MD PhD (1) · Alfonso Cruz-Jentoft, MD (1) · Antonio Cherubini, MD PhD (1) · Corinne M Hohl, MD, MHSc (1) · David O'Sullivan, MPharm (1) · Denis O'Mahony, MD FRCPI (1) · Diana Brixner, PhD, RPh (1) · Jinmin Liu, M.D. (1) · Joesph Eustace, MD FRCPI (1) · Lindsay Elliott, PharmD (1) · Mirko Petrovic, MD PhD (1)
PMID 26478982, PMID 28151991, PMID 30094559, PMID 30760204, PMID 32484853, PMID 34057232, PMID 39513382